Pemetrexed Disodium Heptahydrate API
| Name of Product | Pemetrexed Disodium Heptahydrate |
|---|---|
| CAS No | 357166‑29‑1 |
| Therapeutic use:- | Folate‑antimetabolite (thymidylate synthase inhibitor) – lung & mesothelioma |
| Grade | IP/USP |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Pemetrexed Disodium Heptahydrate is an antifolate chemotherapy agent. It is widely used in oncology.
The product is a folate analog metabolic inhibitor. It usually comes as a raw API.
Pemetrexed Disodium Heptahydrate is widely used in the formulation of oncology medicines.
Therapeutic Applications
First-line treatment for malignant pleural mesothelioma. It’s very useful for control.
Approved for non-small cell lung cancer and even for maintenance therapy.
We also looked at treatments for other solid tumors, like ovarian, bladder, and gastrointestinal cancers.
Antifolate mechanisms and cancer cell resistance are widely researched. They are also useful in oncology.
Specification Parameters
Packaging & Storage
Pemetrexed Disodium Heptahydrate comes in sealed HDPE bottles.
It may also be available in aluminum foil pouches.
Temperature has to be maintained between 2 and 8 °C for long-term stability.
Moreover, I preferred a cool atmosphere and being away from direct sunlight.
Why Choose Us
Choosing us means you get a high-purity API product. We make our products under strict cGMP guidelines.
Offer reliable worldwide delivery with proper documentation.
There a comprehensive compliance documents for regulatory submissions.